申请人:Bristol-Myers
公开号:US05011947A1
公开(公告)日:1991-04-30
Compounds of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each are independently hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy or trifluoromethyl; R is C.sub.1-7 alkyl, C.sub.3-6 cycloalkyl, fluoromethyl, difluoromethyl, trifluoromethyl; A is ##STR2## R.sup.5 is hydrogen, a hydrolyzable ester group or a cation to form a non-toxic pharmaceutically acceptable salt, are novel antihypercholesterolemic agents which inhibit cholesterol biosynthesis. Intermediates and processes for their preparation are disclosed.
该公式化合物的化合物##STR1##其中R.sup.1、R.sup.2、R.sup.3和R.sup.4分别独立地是氢、卤素、C.sub.1-4烷基、C.sub.1-4烷氧基或三氟甲基;R是C.sub.1-7烷基、C.sub.3-6环烷基、氟甲基、二氟甲基、三氟甲基;A是##STR2##R.sup.5是氢、可水解酯基或阳离子,形成无毒的药用可接受盐,是抑制胆固醇生物合成的新型抗高胆固醇药物。公开了其制备的中间体和过程。